UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
June 1, 2021
ALLIED HEALTHCARE PRODUCTS, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 0-19266 | 25-1370721 |
(State or Other Jurisdiction
of Incorporation) | (Commission
File Number) | (IRS Employer
Identification No.) |
1720 Sublette Avenue, St. Louis, Missouri
(Address of principal executive offices) | 63110
(Zip Code) |
| Registrant’s telephone number, including area code |
| (314) 771-2400 |
| |
| Not applicable |
| (Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging Growth Company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading Symbol | Name of Each Exchange on Which Registered |
| Common Stock, $.01 | AHPI | The NASDAQ Stock Market, LLC |
On May 27, 2021, Allied Healthcare Products, Inc. (the “Company”) suffered what it believed to be a cyber-attack impacting certain of its operational and information technology systems. Promptly upon its detection of the incident, the Company began working with cyber defense professionals to analyze and remediate this incident. On June 1, 2021, the Company’s cyber response advisers determined that the incident was due to ransomware. The Company has notified law enforcement and will provide any notices that may be required by applicable law.
Systems recovery efforts are in process and being implemented as quickly as possible, and the Company is working to maintain the business operations and to minimize the impact on its customers and teammates.
Although the Company is working to respond to this incident and will continue to do so, the incident has caused and may continue to cause delays in parts of the Company’s business and may result in a deferral or loss of revenue and incremental costs that may adversely impact the Company’s financial results.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | ALLIED HEALTHCARE PRODUCTS, INC. |
| | | |
| | | |
| Date: June 4, 2021 | By: | /s/ Daniel C. Dunn |
| | | Daniel C. Dunn |
| | | Chief Financial Officer |
